Evidence map›Paper›PMID 39248297›Full record

ReviewEpilepsia open2024

The implications of frailty in older adults with epilepsy.

Syeda Amrah Hashmi, Seerat Sachdeva, Udeept Sindhu, Carolyn Tsai, Kalyanchakradhar Bonda, Mark Keezer, Ifrah Zawar, Vineet Punia

Abstract readReview
In one paragraph

Review in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Syeda Amrah HashmiDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID https://orcid.org/0000-0001-8393-3778
Seerat SachdevaClinical Observer, Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.
Udeept SindhuClinical Observer, Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0003-1383-3514
Carolyn TsaiEpilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0003-1864-371X
Kalyanchakradhar BondaClinical Observer, Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.
Mark KeezerDepartment of Neurosciences, Université de Montréal, Montreal, Quebec, Canada.
Ifrah ZawarDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Vineet PuniaEpilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-0552-6736

Funding

Epilepsy in Alzheimer's disease and related dementiasK23AG084893 · NIA · UNIVERSITY OF VIRGINIA · PI Ifrah Zawar · 2024 to 2026
$575k
NIA NIH HHS K23 AG084893
6 · The paper itself

Abstract

Older adults constitute a large proportion of people with epilepsy (PWE) due to the changing demographics worldwide and epilepsy's natural history. Aging-related pathophysiological changes lower the tolerance and increase our vulnerability to stressors, which manifests as frailty. Frailty is closely associated with adverse health outcomes. This narrative review examines the interplay between frailty and epilepsy, especially in older adults, emphasizing its clinical implications, including its role in managing PWE. Mechanistically, frailty develops through complex interactions among molecular and cellular damage, including genomic instability, mitochondrial dysfunction, and hormonal changes. These contribute to systemic muscle mass, bone density, and organ function decline. The concept of frailty has evolved from a primarily physical syndrome to include social, psychological, and cognitive dimensions. The "phenotypic frailty" model, which focuses on physical performance, and the "deficit accumulation" model, which quantifies health deficits, provide frameworks for understanding and assessing frailty. PWE are potentially more prone to developing frailty due to a higher prevalence of risk factors predisposing to frailty. These include, but are not limited to, polypharmacy, higher comorbidity, low exercise level, social isolation, low vitamin D, and osteoporosis. We lack commercial biomarkers to measure frailty but can diagnose it using self- or healthcare provider-administered frailty scales. Recent attempts to develop a PWE-specific frailty scale are promising. Unlike chronological age, frailty is reversible, so its management using multidisciplinary care teams should be strongly considered. Frailty can affect antiseizure medication (ASM) tolerance secondary to its impact on pharmacokinetics and pharmacodynamics. While frailty's effect on seizure control efficacy of ASM is poorly understood, its undoubted association with overall poor outcomes, including epilepsy surgery, behooves us to consider its presence and implication while treating older PWE. Incorporation of frailty measures in future research is essential to improve our understanding of frailty's role in PWE health. PLAIN LANGUAGE SUMMARY: Frailty is the declining state of the human body. People with epilepsy are more prone to it. It should be factored into their management.

Indexed as

EpilepsyFrailtyAgedAgingAnticonvulsantsComorbidityFrail ElderlyHumansRisk FactorsAnticonvulsantsepilepsyfrailtyolder adultsseizure

Identifiers

PMID39248297
PMCPMC11633683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.